New WLF Paper Details Below-the-Radar Foreign Regulatory Threats to U.S. High Tech

By Harrision Stewart

Economic growth and job creation in the United States today relies heavily upon expansion and innovation from industries which develop and commercialize highly complex technology.  Enterprises and entrepreneurs in these industries require constant access to capital, and investors who can provide such financial resources must consider the potential risks and rewards.  The creation of new … Continued

Last Week at WLF

By Harrision Stewart

Litigation Updates: In re Securities & Exchange Commission Proposed Whistleblower Rules On December 17, 2010, WLF urged the Securities & Exchange Commission (SEC) to revise its proposed rules for implementing a new whistleblower law, before issuing them in final form. In formal comments filed with the SEC, WLF expressed a longstanding interest in the work … Continued

Finger on the Pulse: From Our Blogroll and Beyond

By Harrision Stewart

Plaintiffs in private antitrust suit challenging “reverse payment” drug patent settlements petitions the Supreme Court.  Will FTC amicus brief follow? (FDA Law Blog) So many say so much about Center for Science in the Public Interest’s “Happy Meal suit” (Overlawyered) Professor Ribstein on enduring difficulties with SEC’s Regulation FD (featuring cite to his 2000 WLF … Continued